View in EDS

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern.

Saved in:
Bibliographic Details
Title: Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern.
Authors: Cohen-Dvashi H; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Weinstein J; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel., Katz M; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Eilon-Ashkenazy M; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Mor Y; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Shimon A; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel., Achdout H; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Tamir H; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Israely T; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Strobelt R; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel., Shemesh M; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel., Stoler-Barak L; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Shulman Z; Department of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel., Paran N; Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel., Fleishman SJ; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel., Diskin R; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Source: IScience [iScience] 2022 Oct 21; Vol. 25 (10), pp. 105193. Date of Electronic Publication: 2022 Sep 28.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2022.105193